A pandemic of new coronavirus developed and amplified the race in search of a cure, a medicine that treats the problem and reduces the consequences of the virus in the world population.
As a result, scientists around the world are looking for an antidote to this pandemic agent.
see more
Toyota announces new Corolla in Brazil with UNBELIEVABLE price; look
AMAZING: Scientists find 'prehistoric' penguin alive in New…
In the midst of research, hope arose among all the materials and possibilities put under investigation.
The magazine Antiviral Research published, on April 3, a study of the Monash University, in partnership with the Doherty Institute of Infection and Immunity, on the efficiency and response of a antiparasitic medicine in cell cultures against the new coronavirus, managed for 48 hours.
The study noted that with the use of the drug, the growth and development of the COVID-19 virus was inhibited.
The drug used, called Ivermectin, provided positive results in combating the virus, inserted in a single dose in cell culture.
This drug had already been recognized as effective against Dengue, Zika, Influenza and HIV viruses.
However, the tests were done only in cell cultures, without applications and verification of effectiveness in humans.
In cell culture, during the period of 48 hours, the removal of all viral RNA was observed. In 24 hours, the effectiveness is significant, but not complete.
From these results, it is still necessary to carry out tests in humans to prove its efficiency and safety, self-medication and applicability in the population were rejected with the absence of clinical evidence in humans.
In addition, other different studies are developed in parallel in other universities, creating projects and studies aimed at isolating antibodies that prove to be efficient in combating the new coronavirus.
An example of this is the University of Tsinghua, in Beijing, which isolated antibodies that act against the virus and isolate the cells in the action of infection. This discovery is analyzed for its usefulness in the treatment and prevention of Covid-19.
Meanwhile, at the University of Pittsburh, in the United States, scientists are working on a project to develop an effective vaccine against the virus, with promising results.
See too: